Evidence map›Paper›PMID 30814664›Full record

ArticleScientific reports2019

Vangl2 interaction plays a role in the proteasomal degradation of Prickle2.

Tadahiro Nagaoka, Mikio Furuse, Toshihisa Ohtsuka, Kunihiro Tsuchida, Masashi Kishi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Tadahiro NagaokaDivision for Therapies Against Intractable Diseases, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Aichi, 470-1192, Japan.ORCID 0000-0002-9391-0243
Mikio FuruseDivision of Cell Structure, National Institute for Physiological Sciences, Okazaki, Aichi, 444-8787, Japan.
Toshihisa OhtsukaDepartment of Biochemistry, Faculty of Medicine, University of Yamanashi, Yamanashi, 409-3898, Japan.
Kunihiro TsuchidaDivision for Therapies Against Intractable Diseases, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Aichi, 470-1192, Japan. tsuchida@fujita-hu.ac.jp.ORCID 0000-0002-3983-5756
Masashi KishiNeuroscience Laboratory, Research Institute, Nozaki Tokushukai Hospital, Daito, Osaka, 574-0074, Japan. masashi.kishi@gmail.com.
Fujita Health University · JPFukuoka Tokushukai Hospital · JPNational Institute for Physiological Sciences · JPUniversity of Yamanashi · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The PET and LIM domain-containing protein, Prickle, plays a key role in planar cell polarity (PCP) in Drosophila. It has been reported that mutations in the PRICKLE2 gene, which encodes one of the human orthologues of Prickle, are associated with human diseases such as epilepsy and autism spectrum disorder. To develop preventive and therapeutic strategies for these intractable diseases, we studied the regulation of Prickle2 protein levels in transfected HEK293T cells. Prickle2 levels were negatively regulated by a physical interaction with another PCP protein, Van Gogh-like 2 (Vangl2). The Vangl2-mediated reduction in Prickle2 levels was, at least in part, relieved by proteasome inhibitors or by functional inhibition of the Cullin-1 E3 ubiquitin ligase. Furthermore, the expression of Vangl2 enhanced the polyubiquitination of Prickle2. This ubiquitination was partially blocked by co-expression of a ubiquitin mutant, which cannot be polymerised through their Lys48 residue to induce target proteins toward proteasomal degradation. Together, these results suggest that Prickle2 is polyubiquitinated by the Vangl2 interaction in a Cullin-1-dependent manner to limit its expression levels. This regulation may play a role in the local and temporal fine-tuning of Prickle protein levels during PCP signal-dependent cellular behaviours.

Indexed as

AnimalsAutism Spectrum DisorderCell PolarityCullin ProteinsDNA-Binding ProteinsDrosophila melanogasterDrosophila ProteinsEpilepsyHEK293 CellsHumansIntracellular Signaling Peptides and ProteinsLIM Domain ProteinsMembrane ProteinsProteasome Endopeptidase ComplexProtein BindingProteolysisCullin 1Cullin ProteinsDNA-Binding ProteinsDrosophila ProteinsIntracellular Signaling Peptides and ProteinsLIM Domain ProteinsMembrane Proteinspk protein, DrosophilaPRICKLE2 protein, humanProteasome Endopeptidase ComplexVANGL2 protein, human

Identifiers

PMID30814664
PMCPMC6393536
OpenAlexW2918528059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.